Novacap commits due as poor pipeline hits CLOs
Novacap, the French chemicals and pharmaceuticals firm, had replies due on Wednesday on its €435m seven year cov-lite term loan ‘B’ as the market for European leveraged loans struggled to clear all launched deals and build a decent pipeline.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts